NHS Framework for the NHS London Region, Branded Medicines - Tranche A
Awarded by NHS England · 2020-03-12T10:51:15Z · £602,202,628
Description
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine Offer reference number: CM/PHR/16/5516 CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021…
- Buyer
- NHS England
- Value
- £602,202,628
- Category (CPV)
- Pharmaceutical products
- Award date
- 2020-03-12T10:51:15Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.